Skip to main content
. 2013 Jun 4;8(6):e64947. doi: 10.1371/journal.pone.0064947

Table 1. Sample characteristics.

All patients MARS Discovery MARS Replication Muenster Replication
N = 894 N = 398 N = 249 N = 247 P a
Age, mean (SD), y 48.9 (14.3) 49.1 (14.4) 48.0 (13.6) 49.2 (14.9) .58
Female gender, No. (%) 497 (55.6) 223 (56.0) 128 (51.4) 146 (59.1) .22
Unipolar depression, No. (%) 780 (87.2) 345 (86.7) 231 (92.8) 204 (82.6) <.01
HAM-D at admission, mean (SD) 25.9 (6.6) 24.4 (6.4) 27.1 (5.8) 24.0 (7.2) <.001
HAM-D at discharge, mean (SD) 7.6 (6.0) 9.1 (5.9) 7.1 (6.2) 5.8 (5.2) <.001
Duration of hospital stay (weeks), mean (SD) 11.5 (9.2) 11.5 (7.8) 10.9 (9.0) 12.0 (11.5) .45
Response at week 5, No. (%) 468 (52.3) 192 (50.1) 147 (63.4) 129 (53.1) .01
Remission at discharge, No. (%) 581 (65.0) 204 (60.7) 172 (72.9) 202 (81.8) <.001
Number of previous episodes, mean (SD) 3.01 (5.4) 2.84 (5.1) 3.51 (7.3) 2.76 (2.8) .27
Duration of current episode (weeks), mean (SD) 38.12 (66.0) 41.37 (71.4) 32.63 (55.2) N/A .11
Psychotic symptoms, No. (%) 87 (13.6) 50 (12.6) 37 (15.4) N/A .31
Treatment resistanceb at admission, No. (%) 94 (16.7) 54 (15.4) 40 (18.9) N/A .28
a

ANOVA and Chi-square, respectively, comparing the different samples. For some variables there are missing data and N does not equal number of total patients. Percentages are based on available data.

b

Treatment resistance was defined as at least 2 antidepressant treatment attempts with an adequate duration and dosage according to Souery et al.

N/A: data not available.